Phenylephrine Hydrochloride Injectable Solution
cGMP deviations.
Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.
Subpotent: Out of Specification result observed for Ketorolac assay levels, below the 90.0-110.0% of label claim.
Cause type: Wrong potency / content
Sub- or super-potent product, or a failed content-uniformity / assay test. You may receive too little or too much active ingredient - a direct dosing risk. All wrong potency / content recalls.
MYDRIATIC-4: Tropicamide - Proparacaine - Phenylephrine - Ketorolac Sterile Ophthalmic Solution Drops 1% - 0.5% - 2.5% - 0.5%, 5mL bottle, Imprimis, NJOF, 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852 (844)-446-6979, NDC:71384-632-05
Compare with the code on your package — it is the most precise check available.
Drug: Phenylephrine Category: Eye Drops & Ophthalmic
Low risk, still worth a check. Class III means the product is unlikely to cause harm but breaks an FDA rule (often labeling). If your lot matches, your pharmacy will normally swap it; there is no need for alarm. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.
cGMP deviations.
Incorrect Product Formulation
CGMP Deviations
Sub-Potent Drug: Subpotent assay results during stability testing.
Lack of Assurance of Sterility: Leaking/damaged syringes.
Presence of particulate matter - Glass like particles.
Presence of particulate matter - Glass like particles.
Presence of particulate matter - Glass like particles.
Subpotent Drug
Free recall alerts
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.